Gabriel Braley

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Deepak Cyril D’Souza, Edward Perry, Lisa Macdougall et al. · Neuropsychopharmacology · 2004 · 1K citations · Full text

Cannabis Use, Substance Abuse, Healthy Individuals +14

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Deepak Cyril D’Souza, Walid Abi‐Saab, Steven Madonick et al. · Biological Psychiatry · 2005 · 604 citations

Cannabis Use, Delta-9-tetrahydrocannabinol Effects, Substance Abuse +14

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda et al. · Neuromuscular Disorders · 2019 · 602 citations · Full text

Spinal Disorder, Pediatrics, Nurture Study +7

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

Deepak Cyril D’Souza, Mohini Ranganathan, Gabriel Braley et al. · Neuropsychopharmacology · 2008 · 258 citations · Full text

Cannabis Use, Psychoactive Drug, Psychiatry +14

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans

Deepak Cyril D’Souza, Gabriel Braley, Rebecca Blaise et al. · Psychopharmacology · 2008 · 121 citations · Full text

Cannabis Use, Neuroendocrine Effects, Behavioral Neuroscience +11